https://www.businesswire.com/news/home/20220815005130/en/ImmunogenX-and-Mayo-Clinic-Celiac-Disease-Study-Published-in-Gastroenterology
0
0
8/15/22 at 1:00pm
Organization
Business Wire
32 words
0
Comments
ImmunogenX is pleased to report the successful completion of the CeliacShield™ trial (NCT03585478), focused on treating celiac disease (CeD) patients,
You are the first to view
Create an account
or login to join the discussion